On Thursday, Vaxcyte Inc (NASDAQ: PCVX) was 5.25% up from the session before settling in for the closing price of $29.12. A 52-week range for PCVX has been $27.66 – $121.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -18.91%. With a float of $125.04 million, this company’s outstanding shares have now reached $128.76 million.
The extent of productivity of a business whose workforce counts for 414 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Vaxcyte Inc (PCVX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Vaxcyte Inc stocks. The insider ownership of Vaxcyte Inc is 2.89%, while institutional ownership is 108.16%. The most recent insider transaction that took place on Mar 05 ’25, was worth 353,699. In this transaction SVP, GEN COUNSEL & CORP SEC of this company sold 5,000 shares at a rate of $70.74, taking the stock ownership to the 41,620 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Officer proposed sale 5,000 for $68.87, making the entire transaction worth $344,350.
Vaxcyte Inc (PCVX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -18.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.74% during the next five years compared to -29.88% drop over the previous five years of trading.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
You can see what Vaxcyte Inc (PCVX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 12.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.88, a number that is poised to hit -1.05 in the next quarter and is forecasted to reach -4.60 in one year’s time.
Technical Analysis of Vaxcyte Inc (PCVX)
The latest stats from [Vaxcyte Inc, PCVX] show that its last 5-days average volume of 2.5 million was superior to 1.86 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 36.28%. Additionally, its Average True Range was 4.28.
During the past 100 days, Vaxcyte Inc’s (PCVX) raw stochastic average was set at 4.46%, which indicates a significant decrease from 29.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 264.50% in the past 14 days, which was higher than the 113.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $64.15, while its 200-day Moving Average is $86.23. Now, the first resistance to watch is $31.30. This is followed by the second major resistance level at $31.96. The third major resistance level sits at $33.23. If the price goes on to break the first support level at $29.37, it is likely to go to the next support level at $28.10. The third support level lies at $27.44 if the price breaches the second support level.
Vaxcyte Inc (NASDAQ: PCVX) Key Stats
There are 128,762K outstanding shares of the company, which has a market capitalization of 3.95 billion. As of now, sales total 0 K while income totals -463,930 K. Its latest quarter income was 0 K while its last quarter net income were -137,080 K.
